|
SLC6A6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.54219999999717E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.74579999999902E-05 |
| Normal-vs-Stage2 |
1.492500E-02 |
| Normal-vs-Stage3 |
5.121000E-03 |
| Normal-vs-Stage4 |
1.759820E-02 |
| Stage1-vs-Stage2 |
5.914400E-01 |
| Stage1-vs-Stage3 |
2.557800E-01 |
| Stage1-vs-Stage4 |
4.243200E-01 |
| Stage2-vs-Stage3 |
7.921200E-01 |
| Stage2-vs-Stage4 |
8.427200E-01 |
| Stage3-vs-Stage4 |
9.716200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.66540000000293E-05 |
| Normal-vs-AfricanAmerican |
1.530389999993E-05 |
| Normal-vs-Asian |
5.091200E-01 |
| Caucasian-vs-AfricanAmerican |
9.529500E-02 |
| Caucasian-vs-Asian |
2.275400E-01 |
| AfricanAmerican-vs-Asian |
1.454220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.53530000000557E-05 |
| Normal-vs-Female |
7.808900E-04 |
| Male-vs-Female |
7.345000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.086390E-02 |
| Normal-vs-Age(41-60Yrs) |
3.362200E-04 |
| Normal-vs-Age(61-80Yrs) |
2.574100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.599250E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.161800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.456800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.204000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.246800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.078400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.920200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.828500E-02 |
| Normal-vs-Grade 2 |
1.576690E-04 |
| Normal-vs-Grade 3 |
1.739700E-03 |
| Normal-vs-Grade 4 |
4.166000E-02 |
| Grade 1-vs-Grade 2 |
9.879800E-01 |
| Grade 1-vs-Grade 3 |
7.455000E-01 |
| Grade 1-vs-Grade 4 |
5.925800E-01 |
| Grade 2-vs-Grade 3 |
3.789200E-01 |
| Grade 2-vs-Grade 4 |
2.255800E-01 |
| Grade 3-vs-Grade 4 |
5.562600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.95621999999895E-05 |
| Normal-vs-ccB subtype |
2.139800E-02 |
| ccA subtype-vs-ccB subtype |
2.328000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.245800E-04 |
| Normal-vs-N1 |
4.003200E-01 |
| N0-vs-N1 |
7.026000E-02 |
|
|
